<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">39354366</PMID><DateCompleted><Year>2024</Year><Month>10</Month><Day>02</Day></DateCompleted><DateRevised><Year>2024</Year><Month>10</Month><Day>04</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1689-1392</ISSN><JournalIssue CitedMedium="Internet"><Volume>29</Volume><Issue>1</Issue><PubDate><Year>2024</Year><Month>Oct</Month><Day>01</Day></PubDate></JournalIssue><Title>Cellular &amp; molecular biology letters</Title><ISOAbbreviation>Cell Mol Biol Lett</ISOAbbreviation></Journal><ArticleTitle>The role and therapeutic potential of itaconate in lung disease.</ArticleTitle><Pagination><StartPage>129</StartPage><MedlinePgn>129</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">129</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s11658-024-00642-1</ELocationID><Abstract><AbstractText>Lung diseases triggered by endogenous or exogenous factors have become a major concern, with high morbidity and mortality rates, especially after the coronavirus disease 2019 (COVID-19) pandemic. Inflammation and an over-activated immune system can lead to a cytokine cascade, resulting in lung dysfunction and injury. Itaconate, a metabolite produced by macrophages, has been reported as an effective anti-inflammatory and anti-oxidative stress agent with significant potential in regulating immunometabolism. As a naturally occurring metabolite in immune cells, itaconate has been identified as a potential therapeutic target in lung diseases through its role in regulating inflammation and immunometabolism. This review focuses on the origin, regulation, and function of itaconate in lung diseases, and briefly discusses its therapeutic potential.</AbstractText><CopyrightInformation>© 2024. The Author(s).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>He</LastName><ForeName>Ruyuan</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Hubei Province, 99 Zhangzhidong Road, Wuhan, 430060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Zuo</LastName><ForeName>Yifan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Hubei Province, 99 Zhangzhidong Road, Wuhan, 430060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Yi</LastName><ForeName>Ke</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Hubei Province, 99 Zhangzhidong Road, Wuhan, 430060, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Bohao</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Jilin University, Changchun, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Congkuan</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Hubei Province, 99 Zhangzhidong Road, Wuhan, 430060, China. sck2018@whu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Ning</ForeName><Initials>N</Initials><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Hubei Province, 99 Zhangzhidong Road, Wuhan, 430060, China. md.lining@whu.edu.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Geng</LastName><ForeName>Qing</ForeName><Initials>Q</Initials><Identifier Source="ORCID">0000-0003-4515-5084</Identifier><AffiliationInfo><Affiliation>Department of Thoracic Surgery, Renmin Hospital of Wuhan University, Hubei Province, 99 Zhangzhidong Road, Wuhan, 430060, China. gengqingwhu@whu.edu.cn.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>No. 8210082163</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>82300103</GrantID><Agency>National Natural Science Foundation of China</Agency><Country /></Grant><Grant><GrantID>No.2042021kf0081</GrantID><Agency>Fundamental Research Funds for the Central Universities</Agency><Country /></Grant><Grant><GrantID>2042023kf0011</GrantID><Agency>Fundamental Research Funds for the Central Universities</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D016454">Review</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>10</Month><Day>01</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Cell Mol Biol Lett</MedlineTA><NlmUniqueID>9607427</NlmUniqueID><ISSNLinking>1425-8153</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>Q4516562YH</RegistryNumber><NameOfSubstance UI="C005229">itaconic acid</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D013386">Succinates</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D000893">Anti-Inflammatory Agents</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013386" MajorTopicYN="Y">Succinates</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="Y">Lung Diseases</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086382" MajorTopicYN="Y">COVID-19</DescriptorName><QualifierName UI="Q000276" MajorTopicYN="N">immunology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000893" MajorTopicYN="N">Anti-Inflammatory Agents</DescriptorName><QualifierName UI="Q000627" MajorTopicYN="N">therapeutic use</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000086402" MajorTopicYN="N">SARS-CoV-2</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D018384" MajorTopicYN="N">Oxidative Stress</DescriptorName><QualifierName UI="Q000187" MajorTopicYN="N">drug effects</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D007249" MajorTopicYN="N">Inflammation</DescriptorName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Immunometabolism</Keyword><Keyword MajorTopicYN="N">Inflammation</Keyword><Keyword MajorTopicYN="N">Itaconate</Keyword><Keyword MajorTopicYN="N">Lung diseases</Keyword><Keyword MajorTopicYN="N">Macrophage</Keyword><Keyword MajorTopicYN="N">Metabolite</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>3</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>9</Month><Day>4</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>21</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>10</Month><Day>2</Day><Hour>7</Hour><Minute>20</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>10</Month><Day>1</Day><Hour>23</Hour><Minute>41</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>10</Month><Day>1</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39354366</ArticleId><ArticleId IdType="pmc">PMC11445945</ArticleId><ArticleId IdType="doi">10.1186/s11658-024-00642-1</ArticleId><ArticleId IdType="pii">10.1186/s11658-024-00642-1</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Lareau SC, Fahy B, Meek P, Wang A. Chronic Obstructive Pulmonary Disease (COPD). Am J Resp Crit Care. 2019;199:P1–2. 10.1164/rccm.1991P1.</Citation><ArticleIdList><ArticleId IdType="pubmed">30592446</ArticleId></ArticleIdList></Reference><Reference><Citation>Mokra D. Acute lung injury - from pathophysiology to treatment. Physiol Res. 2020;69:S353–66. 10.33549/physiolres.934602.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8603709</ArticleId><ArticleId IdType="pubmed">33464919</ArticleId></ArticleIdList></Reference><Reference><Citation>Myllarniemi M, Kaarteenaho R. Pharmacological treatment of idiopathic pulmonary fibrosis - preclinical and clinical studies of pirfenidone, nintedanib, and N-acetylcysteine. Eur Cli Respir J. 2015. 10.3402/ecrj.v2.26385.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4629756</ArticleId><ArticleId IdType="pubmed">26557253</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong Q, Chen ES, Zhao C, Jin C. Host-microbiome interaction in lung cancer. Front Immunol. 2021;12:679829. 10.3389/fimmu.2021.679829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8183378</ArticleId><ArticleId IdType="pubmed">34108973</ArticleId></ArticleIdList></Reference><Reference><Citation>Gan PXL, Liao W, Lim HF, Wong WSF. Dexamethasone protects against Aspergillus fumigatus-induced severe asthma via modulating pulmonary immunometabolism. Pharmacol Res. 2023;196:106929. 10.1016/j.phrs.2023.106929.</Citation><ArticleIdList><ArticleId IdType="pubmed">37717682</ArticleId></ArticleIdList></Reference><Reference><Citation>Ning L, Shishi Z, Bo W, Huiqing L. Targeting immunometabolism against acute lung injury. Clin Immunol. 2023;249:109289. 10.1016/j.clim.2023.109289.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10008193</ArticleId><ArticleId IdType="pubmed">36918041</ArticleId></ArticleIdList></Reference><Reference><Citation>Baup S. Ueber eine neue Pyrogen-Citronensäure, und über Benennung der Pyrogen-Säuren überhaupt. Annalen der Pharmacie. 2006;19:29–38. 10.1002/jlac.18360190107.</Citation></Reference><Reference><Citation>Holmes FL. Hans Krebs: Architect of Intermediary Metabolism 1933–1937, Oxford University Press, 1993. 10.1093/oso/9780195076578.001.0001</Citation></Reference><Reference><Citation>Sakai A, Kusumoto A, Kiso Y, Furuya E. Itaconate reduces visceral fat by inhibiting fructose 2,6-bisphosphate synthesis in rat liver. Nutrition. 2004;20:997–1002. 10.1016/j.nut.2004.08.007.</Citation><ArticleIdList><ArticleId IdType="pubmed">15561490</ArticleId></ArticleIdList></Reference><Reference><Citation>Strelko CL, Lu W, Dufort FJ, Seyfried TN, Chiles TC, Rabinowitz JD, Roberts MF. Itaconic acid is a mammalian metabolite induced during macrophage activation. J Am Chem Soc. 2011;133:16386–9. 10.1021/ja2070889.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3216473</ArticleId><ArticleId IdType="pubmed">21919507</ArticleId></ArticleIdList></Reference><Reference><Citation>Sugimoto M, Sakagami H, Yokote Y, Onuma H, Kaneko M, Mori M, Sakaguchi Y, Soga T, Tomita M. Non-targeted metabolite profiling in activated macrophage secretion. Metabolomics. 2011;8:624–33. 10.1007/s11306-011-0353-9.</Citation></Reference><Reference><Citation>Michelucci A, Cordes T, Ghelfi J, Pailot A, Reiling N, Goldmann O, Binz T, Wegner A, Tallam A, Rausell A, Buttini M, Linster CL, Medina E, Balling R, Hiller K. Immune-responsive gene 1 protein links metabolism to immunity by catalyzing itaconic acid production. P Natl Acad Sci USA. 2013;110:7820–5. 10.1073/pnas.1218599110.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3651434</ArticleId><ArticleId IdType="pubmed">23610393</ArticleId></ArticleIdList></Reference><Reference><Citation>Basler T, Jeckstadt S, Valentin-Weigand P, Goethe R. Mycobacterium paratuberculosis, Mycobacterium smegmatis, and lipopolysaccharide induce different transcriptional and post-transcriptional regulation of the IRG1 gene in murine macrophages. J Leukocyte Biol. 2006;79:628–38. 10.1189/jlb.0905520.</Citation><ArticleIdList><ArticleId IdType="pubmed">16415166</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas DM, Francescutti-Verbeem DM, Kuhn DM. Gene expression profile of activated microglia under conditions associated with dopamine neuronal damage. Faseb J. 2006;20:515–7. 10.1096/fj.05-4873fje.</Citation><ArticleIdList><ArticleId IdType="pubmed">16384912</ArticleId></ArticleIdList></Reference><Reference><Citation>Zaslona Z, ONeill LAJ. Cytokine-like roles for metabolites in immunity. Molecular cell. 2020;78:814–23. 10.1016/j.molcel.2020.04.002.</Citation><ArticleIdList><ArticleId IdType="pubmed">32333837</ArticleId></ArticleIdList></Reference><Reference><Citation>Mills EL, Ryan DG, Prag HA, Dikovskaya D, Menon D, Zaslona Z, Jedrychowski MP, Costa ASH, Higgins M, Hams E, Szpyt J, Runtsch MC, King MS, McGouran JF, Fischer R, Kessler BM, McGettrick AF, Hughes MM, Carroll RG, Booty LM, Knatko EV, Meakin PJ, Ashford MLJ, Modis LK, Brunori G, Sevin DC, Fallon PG, Caldwell ST, Kunji ERS, Chouchani ET, Frezza C, Dinkova-Kostova AT, Hartley RC, Murphy MP, ONeill LA. Itaconate is an anti-inflammatory metabolite that activates Nrf2 via alkylation of KEAP1. Nature. 2018;556:113–7. 10.1038/nature25986.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6047741</ArticleId><ArticleId IdType="pubmed">29590092</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordes T, Wallace M, Michelucci A, Divakaruni AS, Sapcariu SC, Sousa C, Koseki H, Cabrales P, Murphy AN, Hiller K, Metallo CM. Immunoresponsive gene 1 and itaconate inhibit succinate dehydrogenase to modulate intracellular succinate levels. J Biol Chem. 2016;291:14274–84. 10.1074/jbc.M115.685792.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4933182</ArticleId><ArticleId IdType="pubmed">27189937</ArticleId></ArticleIdList></Reference><Reference><Citation>Lampropoulou V, Sergushichev A, Bambouskova M, Nair S, Vincent EE, Loginicheva E, Cervantes-Barragan L, Ma X, Huang SC, Griss T, Weinheimer CJ, Khader S, Randolph GJ, Pearce EJ, Jones RG, Diwan A, Diamond MS, Artyomov MN. Itaconate links inhibition of succinate dehydrogenase with macrophage metabolic remodeling and regulation of inflammation. Cell Metab. 2016;24:158–66. 10.1016/j.cmet.2016.06.004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5108454</ArticleId><ArticleId IdType="pubmed">27374498</ArticleId></ArticleIdList></Reference><Reference><Citation>Nemeth B, Doczi J, Csete D, Kacso G, Ravasz D, Adams D, Kiss G, Nagy AM, Horvath G, Tretter L, Mocsai A, Csepanyi-Komi R, Iordanov I, Adam-Vizi V, Chinopoulos C. Abolition of mitochondrial substrate-level phosphorylation by itaconic acid produced by LPS-induced Irg1 expression in cells of murine macrophage lineage. Faseb J. 2016;30:286–300. 10.1096/fj.15-279398.</Citation><ArticleIdList><ArticleId IdType="pubmed">26358042</ArticleId></ArticleIdList></Reference><Reference><Citation>Tang C, Wang X, Xie Y, Cai X, Yu N, Hu Y, Zheng Z. 4-Octyl itaconate activates Nrf2 signaling to inhibit pro-inflammatory cytokine production in peripheral blood mononuclear cells of systemic lupus erythematosus patients. Cell Physiol Biochem. 2018;51:979–90. 10.1159/000495400.</Citation><ArticleIdList><ArticleId IdType="pubmed">30466076</ArticleId></ArticleIdList></Reference><Reference><Citation>Bambouskova M, Gorvel L, Lampropoulou V, Sergushichev A, Loginicheva E, Johnson K, Korenfeld D, Mathyer ME, Kim H, Huang LH, Duncan D, Bregman H, Keskin A, Santeford A, Apte RS, Sehgal R, Johnson B, Amarasinghe GK, Soares MP, Satoh T, Akira S, Hai T, de Guzman Strong C, Auclair K, Roddy TP, Biller SA, Jovanovic M, Klechevsky E, Stewart KM, Randolph GJ, Artyomov MN. Electrophilic properties of itaconate and derivatives regulate the IkappaBzeta-ATF3 inflammatory axis. Nature. 2018;556:501–4. 10.1038/s41586-018-0052-z.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6037913</ArticleId><ArticleId IdType="pubmed">29670287</ArticleId></ArticleIdList></Reference><Reference><Citation>Hooftman A, Angiari S, Hester S, Corcoran SE, Runtsch MC, Ling C, Ruzek MC, Slivka PF, McGettrick AF, Banahan K, Hughes MM, Irvine AD, Fischer R, O’Neill LAJ. The immunomodulatory metabolite itaconate modifies NLRP3 and inhibits inflammasome activation. Cell Metab. 2020;32(468–478):e467. 10.1016/j.cmet.2020.07.016.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7422798</ArticleId><ArticleId IdType="pubmed">32791101</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin W, Qin K, Zhang Y, Jia W, Chen Y, Cheng B, Peng L, Chen N, Liu Y, Zhou W, Wang YL, Chen X, Wang C. S-glycosylation-based cysteine profiling reveals regulation of glycolysis by itaconate. Nat Chem Biol. 2019;15:983–91. 10.1038/s41589-019-0323-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">31332308</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen LL, Morcelle C, Cheng ZL, Chen X, Xu Y, Gao Y, Song J, Li Z, Smith MD, Shi M, Zhu Y, Zhou N, Cheng M, He C, Liu KY, Lu G, Zhang L, Zhang C, Zhang J, Sun Y, Qi T, Lyu Y, Ren ZZ, Tan XM, Yin J, Lan F, Liu Y, Yang H, Qian M, Duan C, Chang X, Zhou Y, Shen L, Baldwin AS, Guan KL, Xiong Y, Ye D. Itaconate inhibits TET DNA dioxygenases to dampen inflammatory responses. Nat Cell Biol. 2022;24:353–63. 10.1038/s41556-022-00853-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9305987</ArticleId><ArticleId IdType="pubmed">35256775</ArticleId></ArticleIdList></Reference><Reference><Citation>Runtsch MC, Angiari S, Hooftman A, Wadhwa R, Zhang Y, Zheng Y, Spina JS, Ruzek MC, Argiriadi MA, McGettrick AF, Mendez RS, Zotta A, Peace CG, Walsh A, Chirillo R, Hams E, Fallon PG, Jayamaran R, Dua K, Brown AC, Kim RY, Horvat JC, Hansbro PM, Wang C, O’Neill LAJ. Itaconate and itaconate derivatives target JAK1 to suppress alternative activation of macrophages. Cell Metab. 2022;34(487–501):e488. 10.1016/j.cmet.2022.02.002.</Citation><ArticleIdList><ArticleId IdType="pubmed">35235776</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Z, Chen C, Yang F, Zeng YX, Sun P, Liu P, Li X. Itaconate is a lysosomal inducer that promotes antibacterial innate immunity. Mol cell. 2022;82(2844–2857):e2810. 10.1016/j.molcel.2022.05.009.</Citation><ArticleIdList><ArticleId IdType="pubmed">35662396</ArticleId></ArticleIdList></Reference><Reference><Citation>Peace CG, O’Neill LA. The role of itaconate in host defense and inflammation. J Clin Invest. 2022;132:e148548. 10.1172/JCI148548.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8759771</ArticleId><ArticleId IdType="pubmed">35040439</ArticleId></ArticleIdList></Reference><Reference><Citation>Winterhoff M, Chen F, Sahini N, Ebensen T, Kuhn M, Kaever V, Bahre H, Pessler F. Establishment, validation, and initial application of a sensitive LC-MS/MS assay for quantification of the naturally occurring isomers itaconate, mesaconate, and citraconate. Metabolites. 2021;11:270. 10.3390/metabo11050270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8146994</ArticleId><ArticleId IdType="pubmed">33925995</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu R, Chen F, Wang N, Tang D, Kang R. ACOD1 in immunometabolism and disease. Cell Mol Immunol. 2020;17:822–33. 10.1038/s41423-020-0489-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7395145</ArticleId><ArticleId IdType="pubmed">32601305</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiao W, Wang L, Xiao R, Wu M, Tan J, He Y. Expression profile of human immune-responsive gene 1 and generation and characterization of polyclonal antiserum. Mol Cell Biochem. 2011;353:177–87. 10.1007/s11010-011-0784-7.</Citation><ArticleIdList><ArticleId IdType="pubmed">21424586</ArticleId></ArticleIdList></Reference><Reference><Citation>Orlowska K, Fling RR, Nault R, Sink WJ, Schilmiller AL, Zacharewski T. Dioxin-elicited decrease in cobalamin redirects propionyl-CoA metabolism to the beta-oxidation-like pathway resulting in acrylyl-CoA conjugate buildup. J Biol Chem. 2022;298:102301. 10.1016/j.jbc.2022.102301.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9418907</ArticleId><ArticleId IdType="pubmed">35931118</ArticleId></ArticleIdList></Reference><Reference><Citation>O’Neill LAJ, Artyomov MN. Itaconate: the poster child of metabolic reprogramming in macrophage function. Nat Rev Immunol. 2019;19:273–81. 10.1038/s41577-019-0128-5.</Citation><ArticleIdList><ArticleId IdType="pubmed">30705422</ArticleId></ArticleIdList></Reference><Reference><Citation>Tallam A, Perumal TM, Antony PM, Jager C, Fritz JV, Vallar L, Balling R, Del Sol A, Michelucci A. Gene regulatory network inference of immunoresponsive gene 1 (IRG1) identifies interferon regulatory factor 1 (IRF1) as its transcriptional regulator in mammalian macrophages. Plos One. 2016;11:e0149050. 10.1371/journal.pone.0149050.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4752512</ArticleId><ArticleId IdType="pubmed">26872335</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuster EM, Epple MW, Glaser KM, Mihlan M, Lucht K, Zimmermann JA, Bremser A, Polyzou A, Obier N, Cabezas-Wallscheid N, Trompouki E, Ballabio A, Vogel J, Buescher JM, Westermann AJ, Rambold AS. TFEB induces mitochondrial itaconate synthesis to suppress bacterial growth in macrophages. Nat Metab. 2022;4:856–66. 10.1038/s42255-022-00605-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9314259</ArticleId><ArticleId IdType="pubmed">35864246</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F, Wu R, Liu J, Kang R, Li J, Tang D. The STING1-MYD88 complex drives ACOD1/IRG1 expression and function in lethal innate immunity. Iscience. 2022;25:104561. 10.1016/j.isci.2022.104561.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9234224</ArticleId><ArticleId IdType="pubmed">35769880</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey JD, Diotallevi M, Nicol T, McNeill E, Shaw A, Chuaiphichai S, Hale A, Starr A, Nandi M, Stylianou E, McShane H, Davis S, Fischer R, Kessler BM, McCullagh J, Channon KM, Crabtree MJ. Nitric oxide modulates metabolic remodeling in inflammatory macrophages through TCA cycle regulation and itaconate accumulation. Cell Rep. 2019;28:218–30. 10.1016/j.celrep.2019.06.018.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6616861</ArticleId><ArticleId IdType="pubmed">31269442</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen YJ, Li GN, Li XJ, Wei LX, Fu MJ, Cheng ZL, Yang Z, Zhu GQ, Wang XD, Zhang C, Zhang JY, Sun YP, Saiyin H, Zhang J, Liu WR, Zhu WW, Guan KL, Xiong Y, Yang Y, Ye D, Chen LL. Targeting IRG1 reverses the immunosuppressive function of tumor-associated macrophages and enhances cancer immunotherapy. Sci Adv. 2023;9:eadg0654. 10.1126/sciadv.adg0654.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10146892</ArticleId><ArticleId IdType="pubmed">37115931</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Quickelberghe E, Martens A, Goeminne LJE, Clement L, van Loo G, Gevaert K. Identification of immune-responsive gene 1 (IRG1) as a target of A20. J Proteome Res. 2018;17:2182–91. 10.1021/acs.jproteome.8b00139.</Citation><ArticleIdList><ArticleId IdType="pubmed">29733654</ArticleId></ArticleIdList></Reference><Reference><Citation>Ganta VC, Choi MH, Kutateladze A, Fox TE, Farber CR, Annex BH. A MicroRNA93-interferon regulatory factor-9-immunoresponsive gene-1-itaconic acid pathway modulates M2-like macrophage polarization to revascularize ischemic muscle. Circulation. 2017;135:2403–25. 10.1161/CIRCULATIONAHA.116.025490.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5503157</ArticleId><ArticleId IdType="pubmed">28356443</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheurlen KM, Chariker JH, Kanaan Z, Littlefield AB, George JB, Seraphine C, Rochet A, Rouchka EC, Galandiuk S. The NOTCH4-GATA4-IRG1 axis as a novel target in early-onset colorectal cancer. Cytokine Growth F R. 2022;67:25–34. 10.1016/j.cytogfr.2022.06.002.</Citation><ArticleIdList><ArticleId IdType="pubmed">35941043</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang J, Jiang Y, Ji R, Jia Y, Wang S, Zhou Z, Wang S, Wang J, Yang Q, Bai H, Zhu X, Jiang B, Ben J, Zhang H, Li X, Chen Q. Macrophage scavenger receptor A1 antagonizes abdominal aortic aneurysm via upregulating IRG1. Biochem Pharmacol. 2023;213:115631. 10.1016/j.bcp.2023.115631.</Citation><ArticleIdList><ArticleId IdType="pubmed">37257722</ArticleId></ArticleIdList></Reference><Reference><Citation>Nelson VL, Nguyen HCB, Garcia-Canaveras JC, Briggs ER, Ho WY, DiSpirito JR, Marinis JM, Hill DA, Lazar MA. PPARgamma is a nexus controlling alternative activation of macrophages via glutamine metabolism. Genes Dev. 2018;32:1035–44. 10.1101/gad.312355.118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6075146</ArticleId><ArticleId IdType="pubmed">30006480</ArticleId></ArticleIdList></Reference><Reference><Citation>De Souza DP, Achuthan A, Lee MK, Binger KJ, Lee MC, Davidson S, Tull DL, McConville MJ, Cook AD, Murphy AJ, Hamilton JA, Fleetwood AJ. Autocrine IFN-I inhibits isocitrate dehydrogenase in the TCA cycle of LPS-stimulated macrophages. J Clin Invest. 2019;129:4239–44. 10.1172/JCI127597.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6763227</ArticleId><ArticleId IdType="pubmed">31483287</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Wang Y, Zhang P, Sun X, Chen X, Yu J, Shi L, Yin Y, Tao K, Li R. Immune-responsive gene 1 protects against liver injury caused by concanavalin A via the activation Nrf2/HO-1 pathway and inhibition of ROS activation pathways. Free Radic Bio Med. 2022;182:108–18. 10.1016/j.freeradbiomed.2022.02.030.</Citation><ArticleIdList><ArticleId IdType="pubmed">35231555</ArticleId></ArticleIdList></Reference><Reference><Citation>Pan J, Zhao X, Lin C, Xu H, Yin Z, Liu T, Zhang S. Immune responsive gene 1, a novel oncogene, increases the growth and tumorigenicity of glioma. Oncol Rep. 2014;32:1957–66. 10.3892/or.2014.3474.</Citation><ArticleIdList><ArticleId IdType="pubmed">25216059</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Wang Y, Wang T, Li C, Shi L, Zhang P, Yin Y, Tao K, Li R. Protective effects of IRG1/itaconate on acute colitis through the inhibition of gasdermins-mediated pyroptosis and inflammation response. Genes Dis. 2023;10:1552–63. 10.1016/j.gendis.2022.05.039.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10311025</ArticleId><ArticleId IdType="pubmed">37397544</ArticleId></ArticleIdList></Reference><Reference><Citation>Singh S, Singh PK, Jha A, Naik P, Joseph J, Giri S, Kumar A. Integrative metabolomics and transcriptomics identifies itaconate as an adjunct therapy to treat ocular bacterial infection. Cell Rep Med. 2021;2:100277. 10.1016/j.xcrm.2021.100277.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8149370</ArticleId><ArticleId IdType="pubmed">34095879</ArticleId></ArticleIdList></Reference><Reference><Citation>Swain A, Bambouskova M, Kim H, Andhey PS, Duncan D, Auclair K, Chubukov V, Simons DM, Roddy TP, Stewart KM, Artyomov MN. Comparative evaluation of itaconate and its derivatives reveals divergent inflammasome and type I interferon regulation in macrophages. Nat Metab. 2020;2:594–602. 10.1038/s42255-020-0210-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7378276</ArticleId><ArticleId IdType="pubmed">32694786</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordes T, Metallo CM. Itaconate alters succinate and coenzyme a metabolism via inhibition of mitochondrial complex II and methylmalonyl-CoA mutase. Metabolites. 2021. 10.3390/metabo11020117.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7922098</ArticleId><ArticleId IdType="pubmed">33670656</ArticleId></ArticleIdList></Reference><Reference><Citation>Mainali R, Buechler N, Otero C, Edwards L, Key CC, Furdui C, Quinn MA. Itaconate stabilizes CPT1a to enhance lipid utilization during inflammation. Elife. 2024. 10.7554/eLife.92420.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10945551</ArticleId><ArticleId IdType="pubmed">38305778</ArticleId></ArticleIdList></Reference><Reference><Citation>Olagnier D, Brandtoft AM, Gunderstofte C, Villadsen NL, Krapp C, Thielke AL, Laustsen A, Peri S, Hansen AL, Bonefeld L, Thyrsted J, Bruun V, Iversen MB, Lin L, Artegoitia VM, Su C, Yang L, Lin R, Balachandran S, Luo Y, Nyegaard M, Marrero B, Goldbach-Mansky R, Motwani M, Ryan DG, Fitzgerald KA, O’Neill LA, Hollensen AK, Damgaard CK, de Paoli FV, Bertram HC, Jakobsen MR, Poulsen TB, Holm CK. Nrf2 negatively regulates STING indicating a link between antiviral sensing and metabolic reprogramming. Nat Commun. 2018;9:3506. 10.1038/s41467-018-05861-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6115435</ArticleId><ArticleId IdType="pubmed">30158636</ArticleId></ArticleIdList></Reference><Reference><Citation>Xin Y, Zou L, Lang S. 4-Octyl itaconate (4-OI) attenuates lipopolysaccharide-induced acute lung injury by suppressing PI3K/Akt/NF-kappaB signaling pathways in mice. Exp Ther Med. 2021;21:141. 10.3892/etm.2020.9573.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7791918</ArticleId><ArticleId IdType="pubmed">33456508</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen M, Sun H, Boot M, Shao L, Chang SJ, Wang W, Lam TT, Lara-Tejero M, Rego EH, Galan JE. Itaconate is an effector of a Rab GTPase cell-autonomous host defense pathway against Salmonella. Science. 2020;369:450–5. 10.1126/science.aaz1333.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8020367</ArticleId><ArticleId IdType="pubmed">32703879</ArticleId></ArticleIdList></Reference><Reference><Citation>Nair S, Huynh JP, Lampropoulou V, Loginicheva E, Esaulova E, Gounder AP, Boon ACM, Schwarzkopf EA, Bradstreet TR, Edelson BT, Artyomov MN, Stallings CL, Diamond MS. Irg1 expression in myeloid cells prevents immunopathology during M. tuberculosis infection. J Exp Med. 2018;215:1035–45. 10.1084/jem.20180118.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5881474</ArticleId><ArticleId IdType="pubmed">29511063</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Shi B, Suo R, Xiong S, Wang X, Liang X, Li X, Li G. Itaconate regulates macrophage function through stressful iron-sulfur cluster disrupting and iron metabolism rebalancing. Faseb J. 2021;35:e21936. 10.1096/fj.202100726RR.</Citation><ArticleIdList><ArticleId IdType="pubmed">34547129</ArticleId></ArticleIdList></Reference><Reference><Citation>Muri J, Wolleb H, Broz P, Carreira EM, Kopf M. Electrophilic Nrf2 activators and itaconate inhibit inflammation at low dose and promote IL-1beta production and inflammatory apoptosis at high dose. Redox Biol. 2020;36:101647. 10.1016/j.redox.2020.101647.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7387846</ArticleId><ArticleId IdType="pubmed">32863237</ArticleId></ArticleIdList></Reference><Reference><Citation>Daniels BP, Kofman SB, Smith JR, Norris GT, Snyder AG, Kolb JP, Gao X, Locasale JW, Martinez J, Gale M Jr, Loo YM, Oberst A. The nucleotide sensor ZBP1 AND Kinase RIPK3 induce the enzyme IRG1 to promote an antiviral metabolic state in neurons. Immunity. 2019;50:64–76. 10.1016/j.immuni.2018.11.017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6342485</ArticleId><ArticleId IdType="pubmed">30635240</ArticleId></ArticleIdList></Reference><Reference><Citation>Azzimato V, Chen P, Barreby E, Morgantini C, Levi L, Vankova A, Jager J, Sulen A, Diotallevi M, Shen JX, Miller A, Ellis E, Ryden M, Naslund E, Thorell A, Lauschke VM, Channon KM, Crabtree MJ, Haschemi A, Craige SM, Mori M, Spallotta F, Aouadi M. Hepatic miR-144 drives fumarase activity preventing NRF2 activation during obesity. Gastroenterology. 2021;161:1982–97. 10.1053/j.gastro.2021.08.030.</Citation><ArticleIdList><ArticleId IdType="pubmed">34425095</ArticleId></ArticleIdList></Reference><Reference><Citation>He W, Henne A, Lauterbach M, Geissmar E, Nikolka F, Kho C, Heinz A, Dostert C, Grusdat M, Cordes T, Harm J, Goldmann O, Ewen A, Verschueren C, Blay-Cadanet J, Geffers R, Garritsen H, Kneiling M, Holm CK, Metallo CM, Medina E, Abdullah Z, Latz E, Brenner D, Hiller K. Mesaconate is synthesized from itaconate and exerts immunomodulatory effects in macrophages. Nat Metab. 2022;4:524–33. 10.1038/s42255-022-00565-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9744384</ArticleId><ArticleId IdType="pubmed">35655024</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao ST, Han C, Xu DQ, Fu XW, Wang JS, Kong LY. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to exert anti-inflammatory effects. Nat Commun. 2019;10:5091. 10.1038/s41467-019-13078-5.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6841710</ArticleId><ArticleId IdType="pubmed">31704924</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang SS, Guo DY, Jia BB, Cai GL, Yan J, Lu Y, Yang ZX. Dimethyl itaconate alleviates the pyroptosis of macrophages through oxidative stress. Bmc Immunol. 2021;22:72. 10.1186/s12865-021-00463-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8573905</ArticleId><ArticleId IdType="pubmed">34749650</ArticleId></ArticleIdList></Reference><Reference><Citation>Waqas SF, Sohail A, Nguyen AHH, Usman A, Ludwig T, Wegner A, Malik MNH, Schuchardt S, Geffers R, Winterhoff M, Merkert S, Martin U, Olmer R, Lachmann N, Pessler F. ISG15 deficiency features a complex cellular phenotype that responds to treatment with itaconate and derivatives. Clin Transl Med. 2022;12:e931. 10.1002/ctm2.931.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9288839</ArticleId><ArticleId IdType="pubmed">35842904</ArticleId></ArticleIdList></Reference><Reference><Citation>Weiss JM, Davies LC, Karwan M, Ileva L, Ozaki MK, Cheng RY, Ridnour LA, Annunziata CM, Wink DA, McVicar DW. Itaconic acid mediates crosstalk between macrophage metabolism and peritoneal tumors. J Clin Invest. 2018;128:3794–805. 10.1172/JCI99169.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6118601</ArticleId><ArticleId IdType="pubmed">29920191</ArticleId></ArticleIdList></Reference><Reference><Citation>Jaiswal AK, Yadav J, Makhija S, Mazumder S, Mitra AK, Suryawanshi A, Sandey M, Mishra A. Irg1/itaconate metabolic pathway is a crucial determinant of dendritic cells immune-priming function and contributes to resolute allergen-induced airway inflammation. Mucosal Immunol. 2022;15:301–13. 10.1038/s41385-021-00462-y.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8866123</ArticleId><ArticleId IdType="pubmed">34671116</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Zhang P, Wang C, Han C, Meng J, Liu X, Xu S, Li N, Wang Q, Shi X, Cao X. Immune responsive gene 1 (IRG1) promotes endotoxin tolerance by increasing A20 expression in macrophages through reactive oxygen species. J Biol Chem. 2013;288:16225–34. 10.1074/jbc.M113.454538.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3675562</ArticleId><ArticleId IdType="pubmed">23609450</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu X, Wu XP, Zhu XL, Li T, Liu Y. IRG1 increases MHC class I level in macrophages through STAT-TAP1 axis depending on NADPH oxidase mediated reactive oxygen species. Int Immunopharmacol. 2017;48:76–83. 10.1016/j.intimp.2017.04.012.</Citation><ArticleIdList><ArticleId IdType="pubmed">28477473</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y, Chen Z, She C, Lin Y, Hong Y, Shi L, Zhang Y, Cao P, Xu X. Four-octyl itaconate activates Nrf2 cascade to protect osteoblasts from hydrogen peroxide-induced oxidative injury. Cell Death Dis. 2020;11:772. 10.1038/s41419-020-02987-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7499214</ArticleId><ArticleId IdType="pubmed">32943614</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu H, Feng Y, Xu M, Yang J, Wang Z, Di G. Four-octyl itaconate activates Keap1-Nrf2 signaling to protect neuronal cells from hydrogen peroxide. Cell Commun Signal. 2018;16:81. 10.1186/s12964-018-0294-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6238317</ArticleId><ArticleId IdType="pubmed">30442144</ArticleId></ArticleIdList></Reference><Reference><Citation>Yi Z, Deng M, Scott MJ, Fu G, Loughran PA, Lei Z, Li S, Sun P, Yang C, Li W, Xu H, Huang F, Billiar TR. Immune-responsive gene 1/itaconate activates nuclear factor erythroid 2-related factor 2 in hepatocytes to protect against liver ischemia-reperfusion injury. Hepatology. 2020;72:1394–411. 10.1002/hep.31147.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7702080</ArticleId><ArticleId IdType="pubmed">31997373</ArticleId></ArticleIdList></Reference><Reference><Citation>Cordes T, Lucas A, Divakaruni AS, Murphy AN, Cabrales P, Metallo CM. Itaconate modulates tricarboxylic acid and redox metabolism to mitigate reperfusion injury. Mol Metab. 2020;32:122–35. 10.1016/j.molmet.2019.11.019.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6961711</ArticleId><ArticleId IdType="pubmed">32029222</ArticleId></ArticleIdList></Reference><Reference><Citation>Seim GL, Britt EC, John SV, Yeo FJ, Johnson AR, Eisenstein RS, Pagliarini DJ, Fan J. Two-stage metabolic remodelling in macrophages in response to lipopolysaccharide and interferon-gamma stimulation. Nat Metab. 2019;1:731–42. 10.1038/s42255-019-0083-2.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7108803</ArticleId><ArticleId IdType="pubmed">32259027</ArticleId></ArticleIdList></Reference><Reference><Citation>He R, Liu B, Xiong R, Geng B, Meng H, Lin W, Hao B, Zhang L, Wang W, Jiang W, Li N, Geng Q. Itaconate inhibits ferroptosis of macrophage via Nrf2 pathways against sepsis-induced acute lung injury. Cell Death Discov. 2022;8:43. 10.1038/s41420-021-00807-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8810876</ArticleId><ArticleId IdType="pubmed">35110526</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu YT, Xu WT, Zheng L, Wang S, Wei J, Liu MY, Zhou HP, Li QF, Shi X, Lv X. 4-octyl itaconate ameliorates alveolar macrophage pyroptosis against ARDS via rescuing mitochondrial dysfunction and suppressing the cGAS/STING pathway. Int Immunopharmacol. 2023;118:110104. 10.1016/j.intimp.2023.110104.</Citation><ArticleIdList><ArticleId IdType="pubmed">37004345</ArticleId></ArticleIdList></Reference><Reference><Citation>Bambouskova M, Potuckova L, Paulenda T, Kerndl M, Mogilenko DA, Lizotte K, Swain A, Hayes S, Sheldon RD, Kim H, Kapadnis U, Ellis AE, Isaguirre C, Burdess S, Laha A, Amarasinghe GK, Chubukov V, Roddy TP, Diamond MS, Jones RG, Simons DM, Artyomov MN. Itaconate confers tolerance to late NLRP3 inflammasome activation. Cell Rep. 2021;34:108756. 10.1016/j.celrep.2021.108756.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8039864</ArticleId><ArticleId IdType="pubmed">33691097</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu K, Huang J, Liu J, Klionsky DJ, Kang R, Tang D. Induction of autophagy-dependent ferroptosis to eliminate drug-tolerant human retinoblastoma cells. Cell Death Dis. 2022;13:521. 10.1038/s41419-022-04974-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9163041</ArticleId><ArticleId IdType="pubmed">35654783</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehra MR, Crespo-Leiro MG, Dipchand A, Ensminger SM, Hiemann NE, Kobashigawa JA, Madsen J, Parameshwar J, Starling RC, Uber PA. International Society for Heart and Lung Transplantation working formulation of a standardized nomenclature for cardiac allograft vasculopathy-2010. J Heart Lung Transpl. 2010;29:717–27. 10.1016/j.healun.2010.05.017.</Citation><ArticleIdList><ArticleId IdType="pubmed">20620917</ArticleId></ArticleIdList></Reference><Reference><Citation>Ortiz-Munoz G, Mallavia B, Bins A, Headley M, Krummel MF, Looney MR. Aspirin-triggered 15-epi-lipoxin A4 regulates neutrophil-platelet aggregation and attenuates acute lung injury in mice. Blood. 2014;124:2625–34. 10.1182/blood-2014-03-562876.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4208278</ArticleId><ArticleId IdType="pubmed">25143486</ArticleId></ArticleIdList></Reference><Reference><Citation>Tasaka S, Amaya F, Hashimoto S, Ishizaka A. Roles of oxidants and redox signaling in the pathogenesis of acute respiratory distress syndrome. Antioxid Redox Sign. 2008;10:739–53. 10.1089/ars.2007.1940.</Citation><ArticleIdList><ArticleId IdType="pubmed">18179359</ArticleId></ArticleIdList></Reference><Reference><Citation>Michalaki C, Albers GJ, Byrne AJ. Itaconate as a key regulator of respiratory disease. Clin Exp Immunol. 2024;215:120–5. 10.1093/cei/uxad127.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10847819</ArticleId><ArticleId IdType="pubmed">38018224</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Cai J, Li C, Yang M, Duan T, Zhao Q, Xi Y, Sun L, He L, Tang C, Sun L. 4-Octyl itaconate attenuates LPS-induced acute kidney injury by activating Nrf2 and inhibiting STAT3 signaling. Mol Med. 2023;29:58. 10.1186/s10020-023-00631-8.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10127401</ArticleId><ArticleId IdType="pubmed">37095432</ArticleId></ArticleIdList></Reference><Reference><Citation>Ni L, Xiao J, Zhang D, Shao Z, Huang C, Wang S, Wu Y, Tian N, Sun L, Wu A, Zhou Y, Wang X, Zhang X. Immune-responsive gene 1/itaconate activates nuclear factor erythroid 2-related factor 2 in microglia to protect against spinal cord injury in mice. Cell Death Dis. 2022;13:140. 10.1038/s41419-022-04592-4.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8831631</ArticleId><ArticleId IdType="pubmed">35145070</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu G, Wu Y, Jin S, Sun J, Wan BB, Zhang J, Wang Y, Gao ZQ, Chen D, Li S, Pang Q, Wang Z. Itaconate ameliorates methicillin-resistant Staphylococcus aureus-induced acute lung injury through the Nrf2/ARE pathway. Ann Transl Med. 2021;9:712. 10.21037/atm-21-1448.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8106008</ArticleId><ArticleId IdType="pubmed">33987410</ArticleId></ArticleIdList></Reference><Reference><Citation>Darvish Khadem M, Tabandeh MR, Haschemi A, Kheirollah A, Shahriari A. Dimethyl itaconate reprograms neurotoxic to neuroprotective primary astrocytes through the regulation of NLRP3 inflammasome and NRF2/HO-1 pathways. Mol Cell Neurosci. 2022;122:103758. 10.1016/j.mcn.2022.103758.</Citation><ArticleIdList><ArticleId IdType="pubmed">35868484</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang S, Zhang X, Zhang H, Lin X, Chen X, Zhang Y, Lin X, Huang L, Zhuge Q. Dimethyl itaconate inhibits LPS-induced microglia inflammation and inflammasome-mediated pyroptosis via inducing autophagy and regulating the Nrf-2/HO-1 signaling pathway. Mol Med Rep. 2021. 10.3892/mmr.2021.12311.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8335742</ArticleId><ArticleId IdType="pubmed">34296312</ArticleId></ArticleIdList></Reference><Reference><Citation>Burczyk G, Cichon I, Kolaczkowska E. Itaconate suppresses formation of Neutrophil Extracellular Traps (NETs): involvement of hypoxia-inducible factor 1alpha (Hif-1alpha) and heme oxygenase (HO-1). Front Immunol. 2022;13:864638. 10.3389/fimmu.2022.864638.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9273966</ArticleId><ArticleId IdType="pubmed">35837403</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu L, Wu Z, Liu Y, Ming Y, Xie P, Jiang M, Qi Y. Acod1/itaconate activates Nrf2 in pulmonary microvascular endothelial cells to protect against the obesity-induced pulmonary microvascular endotheliopathy. Respir Res. 2024;25:205. 10.1186/s12931-024-02827-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC11088094</ArticleId><ArticleId IdType="pubmed">38730297</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Fu C, Sun Y, You Y, Wang T, Zhang Y, Xia H, Wang X. Itaconic acid regulation of TFEB-mediated autophagy flux alleviates hyperoxia-induced bronchopulmonary dysplasia. Redox Biol. 2024;72:103115. 10.1016/j.redox.2024.103115.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10998238</ArticleId><ArticleId IdType="pubmed">38554522</ArticleId></ArticleIdList></Reference><Reference><Citation>Gu L, Lin J, Wang Q, Li C, Peng X, Fan Y, Lu C, Lin H, Niu Y, Zhu G, Zhao G. Dimethyl itaconate protects against fungal keratitis by activating the Nrf2/HO-1 signaling pathway. Immunol Cell Biol. 2020;98:229–41. 10.1111/imcb.12316.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7065235</ArticleId><ArticleId IdType="pubmed">31943336</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassileva M, Malusa E, Eichler-Lobermann B, Vassilev N. Aspegillus terreus: from soil to industry and back. Microorganisms. 2020. 10.3390/microorganisms8111655.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7692665</ArticleId><ArticleId IdType="pubmed">33113865</ArticleId></ArticleIdList></Reference><Reference><Citation>Sohail A, Iqbal AA, Sahini N, Chen F, Tantawy M, Waqas SFH, Winterhoff M, Ebensen T, Schultz K, Geffers R, Schughart K, Preusse M, Shehata M, Bahre H, Pils MC, Guzman CA, Mostafa A, Pleschka S, Falk C, Michelucci A, Pessler F. Itaconate and derivatives reduce interferon responses and inflammation in influenza A virus infection. PLoS Pathog. 2022;18:e1010219. 10.1371/journal.ppat.1010219.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8846506</ArticleId><ArticleId IdType="pubmed">35025971</ArticleId></ArticleIdList></Reference><Reference><Citation>Waqas FH, Shehata M, Elgaher WAM, Lacour A, Kurmasheva N, Begnini F, Kiib AE, Dahlmann J, Chen C, Pavlou A, Poulsen TB, Merkert S, Martin U, Olmer R, Olagnier D, Hirsch AKH, Pleschka S, Pessler F. NRF2 activators inhibit influenza A virus replication by interfering with nucleo-cytoplasmic export of viral RNPs in an NRF2-independent manner. PLoS Pathog. 2023;19:e1011506. 10.1371/journal.ppat.1011506.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10374058</ArticleId><ArticleId IdType="pubmed">37459366</ArticleId></ArticleIdList></Reference><Reference><Citation>Ribo-Molina P, Weiss HJ, Susma B, van Nieuwkoop S, Persoons L, Zheng Y, Ruzek M, Daelemans D, Fouchier RAM, O’Neill LAJ, van den Hoogen BG. 4-Octyl itaconate reduces influenza A replication by targeting the nuclear export protein CRM1. J Virol. 2023;97:e0132523. 10.1128/jvi.01325-23.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10617539</ArticleId><ArticleId IdType="pubmed">37823646</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu X, Guo Y, Liu Z, Yang J, Tang H, Wang Y. Itaconic acid exerts anti-inflammatory and antibacterial effects via promoting pentose phosphate pathway to produce ROS. Sci Rep. 2021;11:18173. 10.1038/s41598-021-97352-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8438069</ArticleId><ArticleId IdType="pubmed">34518559</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie LY, Xu YB, Ding XQ, Liang S, Li DL, Fu AK, Zhan XA. Itaconic acid and dimethyl itaconate exert antibacterial activity in carbon-enriched environments through the TCA cycle. Biomed Pharmacother. 2023;167:115487. 10.1016/j.biopha.2023.115487.</Citation><ArticleIdList><ArticleId IdType="pubmed">37713987</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen TV, Alfaro AC, Young T, Green S, Zarate E, Merien F. Itaconic acid inhibits growth of a pathogenic marine Vibrio strain: a metabolomics approach. Sci Rep. 2019;9:5937. 10.1038/s41598-019-42315-6.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6459830</ArticleId><ArticleId IdType="pubmed">30976014</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Qin W, Liu D, Liu Y, Wang C. Chemoproteomic profiling of itaconations in Salmonella. Chem Sci. 2021;12:6059–63. 10.1039/d1sc00660f.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8098682</ArticleId><ArticleId IdType="pubmed">33996001</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhusal RP, Bashiri G, Kwai BXC, Sperry J, Leung IKH. Targeting isocitrate lyase for the treatment of latent tuberculosis. Drug Discov Today. 2017;22:1008–16. 10.1016/j.drudis.2017.04.012.</Citation><ArticleIdList><ArticleId IdType="pubmed">28458043</ArticleId></ArticleIdList></Reference><Reference><Citation>Loi VV, Busche T, Kuropka B, Muller S, Methling K, Lalk M, Kalinowski J, Antelmann H. Staphylococcus aureus adapts to the immunometabolite itaconic acid by inducing acid and oxidative stress responses including S-bacillithiolations and S-itaconations. Free Radic Bio Med. 2023;208:859–76. 10.1016/j.freeradbiomed.2023.09.031.</Citation><ArticleIdList><ArticleId IdType="pubmed">37793500</ArticleId></ArticleIdList></Reference><Reference><Citation>Ki N, Kim J, Jo I, Hyun Y, Ryu S, Ha NC. Isocitrate binds to the itaconic acid-responsive LysR-type transcriptional regulator RipR in Salmonella pathogenesis. J Biol Chem. 2022;298:102562. 10.1016/j.jbc.2022.102562.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9637912</ArticleId><ArticleId IdType="pubmed">36198361</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhu N, Zhang D, Wang W, Li X, Yang B, Song J, Zhao X, Huang B, Shi W, Lu R, Niu P, Zhan F, Ma X, Wang D, Xu W, Wu G, Gao GF, Tan W. Novel coronavirus and T. research a novel coronavirus from patients with pneumonia in China, 2019. New Engl J Med. 2020;382:727–33. 10.1056/NEJMoa2001017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7092803</ArticleId><ArticleId IdType="pubmed">31978945</ArticleId></ArticleIdList></Reference><Reference><Citation>Mehta P, McAuley DF, Brown M, Sanchez E, Tattersall RS, Manson JJ, U. K. Hlh Across Speciality Collaboration. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395:1033–4. 10.1016/S0140-6736(20)30628-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7270045</ArticleId><ArticleId IdType="pubmed">32192578</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma G, Dhawan M, Saied AA, Kaur G, Kumar R, Emran TB. Immunomodulatory approaches in managing lung inflammation in COVID-19: a double-edge sword. Immun Inflamm Dis. 2023;11:e1020. 10.1002/iid3.1020.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10521379</ArticleId><ArticleId IdType="pubmed">37773723</ArticleId></ArticleIdList></Reference><Reference><Citation>Malemnganba T, Rattan A, Prajapati VK. Decoding macrophage immunometabolism in human viral infection. Adv Protein Chem Struct Biol. 2024;140:493–523. 10.1016/bs.apcsb.2023.12.003.</Citation><ArticleIdList><ArticleId IdType="pubmed">38762278</ArticleId></ArticleIdList></Reference><Reference><Citation>Olagnier D, Farahani E, Thyrsted J, Blay-Cadanet J, Herengt A, Idorn M, Hait A, Hernaez B, Knudsen A, Iversen MB, Schilling M, Jorgensen SE, Thomsen M, Reinert LS, Lappe M, Hoang HD, Gilchrist VH, Hansen AL, Ottosen R, Nielsen CG, Moller C, van der Horst D, Peri S, Balachandran S, Huang J, Jakobsen M, Svenningsen EB, Poulsen TB, Bartsch L, Thielke AL, Luo Y, Alain T, Rehwinkel J, Alcami A, Hiscott J, Mogensen TH, Paludan SR, Holm CK. SARS-CoV2-mediated suppression of NRF2-signaling reveals potent antiviral and anti-inflammatory activity of 4-octyl-itaconate and dimethyl fumarate. Nat Commun. 2020;11:4938. 10.1038/s41467-020-18764-3.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7532469</ArticleId><ArticleId IdType="pubmed">33009401</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Wang J, Wang L, Aliyari S, Cheng G. SARS-CoV-2 virus NSP14 Impairs NRF2/HMOX1 activation by targeting Sirtuin 1. Cell Mol Immunol. 2022;19:872–82. 10.1038/s41423-022-00887-w.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9217730</ArticleId><ArticleId IdType="pubmed">35732914</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen V, Zhang Y, Gao C, Cao X, Tian Y, Carver W, Kiaris H, Cui T, Tan W. The spike protein of SARS-CoV-2 impairs lipid metabolism and increases susceptibility to lipotoxicity: implication for a role of Nrf2. Cells. 2022. 10.3390/cells11121916.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9221434</ArticleId><ArticleId IdType="pubmed">35741045</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao S, Ghosh A, Lo CS, Chenier I, Scholey JW, Filep JG, Ingelfinger JR, Zhang SL, Chan JSD. Nrf2 deficiency upregulates intrarenal angiotensin-converting enzyme-2 and angiotensin 1–7 receptor expression and attenuates hypertension and nephropathy in diabetic mice. Endocrinology. 2018;159:836–52. 10.1210/en.2017-00752.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5774246</ArticleId><ArticleId IdType="pubmed">29211853</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan TAJ, Hooftman A, Rehill AM, Johansen MD, Brien ECO, Toller-Kawahisa JE, Wilk MM, Day EA, Weiss HJ, Sarvari P, Vozza EG, Schramm F, Peace CG, Zotta A, Miemczyk S, Nalkurthi C, Hansbro NG, McManus G, O’Doherty L, Gargan S, Long A, Dunne J, Cheallaigh CN, Conlon N, Carty M, Fallon PG, Mills KHG, Creagh EM, Donnell JSO, Hertzog PJ, Hansbro PM, McLoughlin RM, Wygrecka M, Preston RJS, Zaslona Z, O’Neill LAJ. Dimethyl fumarate and 4-octyl itaconate are anticoagulants that suppress tissue factor in macrophages via inhibition of type I interferon. Nat Commun. 2023;14:3513. 10.1038/s41467-023-39174-1.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10265568</ArticleId><ArticleId IdType="pubmed">37316487</ArticleId></ArticleIdList></Reference><Reference><Citation>Lederer DJ, Martinez FJ. Idiopathic pulmonary fibrosis. New Engl J Med. 2018;378:1811–23. 10.1056/NEJMra1705751.</Citation><ArticleIdList><ArticleId IdType="pubmed">29742380</ArticleId></ArticleIdList></Reference><Reference><Citation>Thannickal VJ, Toews GB, White ES, Lynch JP 3rd, Martinez FJ. Mechanisms of pulmonary fibrosis. Annu Rev Med. 2004;55:395–417. 10.1146/annurev.med.55.091902.103810.</Citation><ArticleIdList><ArticleId IdType="pubmed">14746528</ArticleId></ArticleIdList></Reference><Reference><Citation>Ogger PP, Albers GJ, Hewitt RJ, O’Sullivan BJ, Powell JE, Calamita E, Ghai P, Walker SA, McErlean P, Saunders P, Kingston S, Molyneaux PL, Halket JM, Gray R, Chambers DC, Maher TM, Lloyd CM, Byrne AJ. Itaconate controls the severity of pulmonary fibrosis. Sci Immunol. 2020;5:eabc1884. 10.1126/sciimmunol.abc1884.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7116646</ArticleId><ArticleId IdType="pubmed">33097591</ArticleId></ArticleIdList></Reference><Reference><Citation>Han YY, Gu X, Yang CY, Ji HM, Lan YJ, Bi YQ, Si R, Qu J, Cheng MH, Gao J. Protective effect of dimethyl itaconate against fibroblast-myofibroblast differentiation during pulmonary fibrosis by inhibiting TXNIP. J Cell Physiol. 2021;236:7734–44. 10.1002/jcp.30456.</Citation><ArticleIdList><ArticleId IdType="pubmed">34061990</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao W, Li M, Cai Q, Wu S, Li X, He Q, Hu Y. Roles of NRF2 in fibrotic diseases: from mechanisms to therapeutic approaches. Front Physiol. 2022;13:889792. 10.3389/fphys.2022.889792.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9203969</ArticleId><ArticleId IdType="pubmed">35721561</ArticleId></ArticleIdList></Reference><Reference><Citation>Sockrider M, Fussner L. What Is Asthma? Am J Resp Crit Care. 2020;202:P25–6. 10.1164/rccm.2029P25.</Citation><ArticleIdList><ArticleId IdType="pubmed">33124914</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang L, Chen X, Li X, Liu D, Wang X, Chang X, Guo Y. Developing a novel strategy for COPD therapy by targeting Nrf2 and metabolism reprogramming simultaneously. Free Radic Bio Med. 2021;169:436–45. 10.1016/j.freeradbiomed.2021.03.039.</Citation><ArticleIdList><ArticleId IdType="pubmed">33812998</ArticleId></ArticleIdList></Reference><Reference><Citation>Bewley MA, Preston JA, Mohasin M, Marriott HM, Budd RC, Swales J, Collini P, Greaves DR, Craig RW, Brightling CE, Donnelly LE, Barnes PJ, Singh D, Shapiro SD, Whyte MKB, Dockrell DH. Impaired mitochondrial microbicidal responses in chronic obstructive pulmonary disease macrophages. Am J Resp Crit Care. 2017;196:845–55. 10.1164/rccm.201608-1714OC.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5649972</ArticleId><ArticleId IdType="pubmed">28557543</ArticleId></ArticleIdList></Reference><Reference><Citation>Bade BC, Dela CS. Cruz lung cancer 2020: epidemiology, etiology, and prevention. Clin Chest Med. 2020;41:1–24. 10.1016/j.ccm.2019.10.001.</Citation><ArticleIdList><ArticleId IdType="pubmed">32008623</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Wang Y, Huang Y, Yu J, Wang T, Li C, Yang L, Zhang P, Shi L, Yin Y, Tao K, Li R. 4-Octyl itaconate inhibits aerobic glycolysis by targeting GAPDH to promote cuproptosis in colorectal cancer. Biomed Pharmacother. 2023;159:114301. 10.1016/j.biopha.2023.114301.</Citation><ArticleIdList><ArticleId IdType="pubmed">36706634</ArticleId></ArticleIdList></Reference><Reference><Citation>Gautam AK, Kumar P, Raj R, Kumar D, Bhattacharya B, Rajinikanth PS, Chidambaram K, Mahata T, Maity B, Saha S. Preclinical evaluation of dimethyl itaconate against hepatocellular carcinoma via activation of the e/iNOS-mediated NF-kappaB-dependent apoptotic pathway. Front Pharmacol. 2021;12:823285. 10.3389/fphar.2021.823285.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8795766</ArticleId><ArticleId IdType="pubmed">35095533</ArticleId></ArticleIdList></Reference><Reference><Citation>Hayashi K, Nakazato Y, Ouchi M, Fujita T, Endou H, Chida M. Antitumor effect of dimethyl itaconate on thymic carcinoma by targeting LDHA-mTOR axis. Life Sci. 2021;282:119847. 10.1016/j.lfs.2021.119847.</Citation><ArticleIdList><ArticleId IdType="pubmed">34293399</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang J, Lu Q, Cai J, Wang Y, Lai X, Qiu Y, Huang Y, Ke Q, Zhang Y, Guan Y, Wu H, Wang Y, Liu X, Shi Y, Zhang K, Wang M, Peng Xiang A. Nestin regulates cellular redox homeostasis in lung cancer through the Keap1-Nrf2 feedback loop. Nat Commun. 2019;10:5043. 10.1038/s41467-019-12925-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6834667</ArticleId><ArticleId IdType="pubmed">31695040</ArticleId></ArticleIdList></Reference><Reference><Citation>Scheurlen KM, Snook DL, Walter MN, Cook CN, Fiechter CR, Pan J, Beal RJ, Galandiuk S. Itaconate and leptin affecting PPARgamma in M2 macrophages: a potential link to early-onset colorectal cancer. Surgery. 2022;171:650–6. 10.1016/j.surg.2021.10.054.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8885843</ArticleId><ArticleId IdType="pubmed">34876290</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao H, Teng D, Yang L, Xu X, Chen J, Jiang T, Feng AY, Zhang Y, Frederick DT, Gu L, Cai L, Asara JM, Pasca di Magliano M, Boland GM, Flaherty KT, Swanson KD, Liu D, Rabinowitz JD, Zheng B. Myeloid-derived itaconate suppresses cytotoxic CD8(+) T cells and promotes tumour growth. Nat Metab. 2022;4:1660–73. 10.1038/s42255-022-00676-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10593361</ArticleId><ArticleId IdType="pubmed">36376563</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao Y, Liu Z, Liu G, Zhang Y, Liu S, Gan D, Chang W, Peng X, Sung ES, Gilbert K, Zhu Y, Wang X, Zeng Z, Baldwin H, Ren G, Weaver J, Huron A, Mayberry T, Wang Q, Wang Y, Diaz-Rubio ME, Su X, Stack MS, Zhang S, Lu X, Sheldon RD, Li J, Zhang C, Wan J, Lu X. Neutrophils resist ferroptosis and promote breast cancer metastasis through aconitate decarboxylase 1. Cell Metab. 2023;35:1688–703. 10.1016/j.cmet.2023.09.004.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10558089</ArticleId><ArticleId IdType="pubmed">37793345</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Su S, Zhu Y, Cheng X, Cheng C, Chen L, Lei A, Zhang L, Xu Y, Ye D, Zhang Y, Li W, Zhang J. Metabolic reprogramming via ACOD1 depletion enhances function of human induced pluripotent stem cell-derived CAR-macrophages in solid tumors. Nat Commun. 2023;14:5778. 10.1038/s41467-023-41470-9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10507032</ArticleId><ArticleId IdType="pubmed">37723178</ArticleId></ArticleIdList></Reference><Reference><Citation>ElAzzouny M, Tom CT, Evans CR, Olson LL, Tanga MJ, Gallagher KA, Martin BR, Burant CF. Dimethyl itaconate is not metabolized into itaconate intracellularly. J Biol Chem. 2017;292:4766–9. 10.1074/jbc.C117.775270.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5377792</ArticleId><ArticleId IdType="pubmed">28188288</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen F, Elgaher WAM, Winterhoff M, Bussow K, Waqas FH, Graner E, Pires-Afonso Y, Casares Perez L, de la Vega L, Sahini N, Czichon L, Zobl W, Zillinger T, Shehata M, Pleschka S, Bahre H, Falk C, Michelucci A, Schuchardt S, Blankenfeldt W, Hirsch AKH, Pessler F. Citraconate inhibits ACOD1 (IRG1) catalysis, reduces interferon responses and oxidative stress, and modulates inflammation and cell metabolism. Nat Metab. 2022;4:534–46. 10.1038/s42255-022-00577-x.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9170585</ArticleId><ArticleId IdType="pubmed">35655026</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Z, Zheng W, Kong W, Zeng T. Itaconate: a potent macrophage immunomodulator. Inflammation. 2023;46:1177–91. 10.1007/s10753-023-01819-0.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10159227</ArticleId><ArticleId IdType="pubmed">37142886</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu D, Xiao W, Li H, Zhang Y, Yuan S, Li C, Dong S, Wang C. Discovery of itaconate-mediated lysine acylation. J Am Chem Soc. 2023;145:12673–81. 10.1021/jacs.3c02332.</Citation><ArticleIdList><ArticleId IdType="pubmed">37271942</ArticleId></ArticleIdList></Reference><Reference><Citation>Hu Z, Xu D, Meng H, Liu W, Zheng Q, Wang J. 4-octyl itaconate protects against oxidative stress-induced liver injury by activating the Nrf2/Sirt3 pathway through AKT and ERK1/2 phosphorylation. Biochem Pharmacol. 2024;220:115992. 10.1016/j.bcp.2023.115992.</Citation><ArticleIdList><ArticleId IdType="pubmed">38128618</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang X, Kong W, Yang R, Yang C. 4-octyl itaconate ameliorates ventilator-induced lung injury. Arch Biochem Biophys. 2024;752:109853. 10.1016/j.abb.2023.109853.</Citation><ArticleIdList><ArticleId IdType="pubmed">38086523</ArticleId></ArticleIdList></Reference><Reference><Citation>Ryan DG, Murphy MP, Frezza C, Prag HA, Chouchani ET, O’Neill LA, Mills EL. Coupling Krebs cycle metabolites to signalling in immunity and cancer. Nat Metab. 2019;1:16–33. 10.1038/s42255-018-0014-7.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6485344</ArticleId><ArticleId IdType="pubmed">31032474</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen X, Li C, Cao X, Jia X, Chen X, Wang Z, Xu W, Dai F, Zhang S. Mitochondria-targeted supramolecular coordination container encapsulated with exogenous itaconate for synergistic therapy of joint inflammation. Theranostics. 2022;12:3251–72. 10.7150/thno.70623.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC9065189</ArticleId><ArticleId IdType="pubmed">35547753</ArticleId></ArticleIdList></Reference><Reference><Citation>Riquelme SA, Liimatta K, Lung TWF, Fields B, Ahn D, Chen D, Lozano C, Saenz Y, Uhlemann AC, Kahl BC, Britto CJ, DiMango E, Prince A. Pseudomonas aeruginosa utilizes host-derived itaconate to redirect its metabolism to promote biofilm formation. Cell Metab. 2020;31:1091–106. 10.1016/j.cmet.2020.04.017.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7272298</ArticleId><ArticleId IdType="pubmed">32428444</ArticleId></ArticleIdList></Reference><Reference><Citation>Li Y, Chen X, Zhang H, Xiao J, Yang C, Chen W, Wei Z, Chen X, Liu J. 4-Octyl itaconate alleviates lipopolysaccharide-induced acute lung injury in mice by inhibiting oxidative stress and inflammation. Drug Des Dev Ther. 2020;14:5547–58. 10.2147/DDDT.S280922.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7751705</ArticleId><ArticleId IdType="pubmed">33364751</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang W, Wang Y, Huang Y, Wang T, Li C, Zhang P, Liu W, Yin Y, Li R, Tao K. Immune Response Gene-1 [IRG1]/itaconate protect against multi-organ injury via inhibiting gasdermin D-mediated pyroptosis and inflammatory response. Inflammopharmacology. 2024;32:419–32. 10.1007/s10787-023-01278-x.</Citation><ArticleIdList><ArticleId IdType="pubmed">37470905</ArticleId></ArticleIdList></Reference><Reference><Citation>Zeng YR, Song JB, Wang D, Huang ZX, Zhang C, Sun YP, Shu G, Xiong Y, Guan KL, Ye D, Wang P. The immunometabolite itaconate stimulates OXGR1 to promote mucociliary clearance during the pulmonary innate immune response. J Clin Invest. 2023. 10.1172/JCI160463.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10014103</ArticleId><ArticleId IdType="pubmed">36919698</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomlinson KL, Riquelme SA, Baskota SU, Drikic M, Monk IR, Stinear TP, Lewis IA, Prince AS. Staphylococcus aureus stimulates neutrophil itaconate production that suppresses the oxidative burst. Cell Rep. 2023;42:112064. 10.1016/j.celrep.2023.112064.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC10387506</ArticleId><ArticleId IdType="pubmed">36724077</ArticleId></ArticleIdList></Reference><Reference><Citation>Demars A, Vitali A, Comein A, Carlier E, Azouz A, Goriely S, Smout J, Flamand V, Van Gysel M, Wouters J, Abendroth J, Edwards TE, Machelart A, Hoffmann E, Brodin P, De Bolle X, Muraille E. Aconitate decarboxylase 1 participates in the control of pulmonary Brucella infection in mice. PLoS Pathog. 2021;17:e1009887. 10.1371/journal.ppat.1009887.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8443048</ArticleId><ArticleId IdType="pubmed">34525130</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun KA, Li Y, Meliton AY, Woods PS, Kimmig LM, Cetin-Atalay R, Hamanaka RB, Mutlu GM. Endogenous itaconate is not required for particulate matter-induced NRF2 expression or inflammatory response. Elife. 2020. 10.7554/eLife.54877.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7185992</ArticleId><ArticleId IdType="pubmed">32255424</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu YX, Zhang YR, Jiang FJ, He S, Zhang YL, Chen D, Tong Y, Nie YJ, Pang QF. 4-OI ameliorates bleomycin-induced pulmonary fibrosis by activating Nrf2 and suppressing macrophage-mediated epithelial-mesenchymal transition. Inflamm Res. 2023;72:1133–45. 10.1007/s00011-023-01733-z.</Citation><ArticleIdList><ArticleId IdType="pubmed">37169970</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>